RBFOX2 and adrenal cortex carcinoma: Furthermore, increased RBFOX2 levels were associated with shorter DFS in ACC, BLCA, COAD, KIRP, OV, PAAD, PCPG, and UCEC patients (Supplementary Figure S3).